Evaluation of an Objective Measure of Mealtime Insulin Administration Frequency in Emerging Adults with Type 1 Diabetes

Diabetes Technology and Therapeutics · Published 2026-07-17 · DOI 10.1177/15209156261469645

Authors (4)

Jessica S. Pierce, Mark A. Clements, Brent Lockee, Susana R. Patton

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Pierce, J., Clements, M., Lockee, B., et al. (2026). Evaluation of an Objective Measure of Mealtime Insulin Administration Frequency in Emerging Adults with Type 1 Diabetes. Diabetes Technology and Therapeutics. https://doi.org/10.1177/15209156261469645

Related articles

• Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use · Diabetes Technology and Therapeutics · 2026 · Same journal
• The Virtual Diabetes Control and Complications Trial #4: Relationship of HbA1c and Continuous Glucose Monitoring Metrics with Severe Hypoglycemic Events · Diabetes Technology and Therapeutics · 2026 · Same journal
• A Simple Meal Bolus Strategy is Effective in Adolescents and Young Adults with Type 1 Diabetes on Multiple Automated Insulin Delivery Systems · Diabetes Technology and Therapeutics · 2026 · Same journal
• Continuous Glucose Monitoring Metrics in Women with Type 2 Diabetes in Pregnancy: The TIMELY Observational Cohort Study · Diabetes Technology and Therapeutics · 2026 · Same journal
• Primary Care and Diabetes Technologies and Treatments · Diabetes Technology and Therapeutics · 2026 · Same journal
• Glucose Predictions Improve Glycemic Control: A Digital Twin Evaluation · Diabetes Technology and Therapeutics · 2026 · Same journal
• Comparative Analysis of Capillary HbA1c and CGM-Derived GMI Estimates: A Real-World Data from a Single Center · Diabetes Technology and Therapeutics · 2026 · Same journal
• Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes · Diabetes Technology and Therapeutics · 2026 · Same journal
• Response to: Quiros et al.: Baseline Glycemic Control and AID Efficacy in Type 1 Diabetes and Pregnancy · Diabetes Technology and Therapeutics · 2026 · Same journal
• Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT Trial · Diabetes Technology and Therapeutics · 2026 · Same journal